Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Stryker Corporation SYK
$283.44
-$1.67 (-0.59%)
На 18:00, 12 мая 2023
-1.38%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
108841205760.00000000
-
week52high
306.56
-
week52low
188.84
-
Revenue
18449000000
-
P/E TTM
41
-
Beta
0.94602000
-
EPS
6.86000000
-
Last Dividend
3.00000000
-
Next Earnings Date
24 июл 2023 г. в 20:05
Описание компании
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Edward Jones | Buy | Hold | 28 июл 2022 г. |
Wells Fargo | Overweight | Overweight | 27 июл 2022 г. |
RBC Capital | Sector Perform | Sector Perform | 27 июл 2022 г. |
Piper Sandler | Overweight | Overweight | 27 июл 2022 г. |
Cowen & Co. | Outperform | Outperform | 22 июл 2022 г. |
Piper Sandler | Overweight | Overweight | 14 сент 2022 г. |
BTIG | Buy | Buy | 06 сент 2022 г. |
Barclays | Overweight | 18 окт 2022 г. | |
BTIG | Buy | Buy | 17 окт 2022 г. |
Jefferies | Buy | 12 окт 2022 г. | |
Wells Fargo | Overweight | Overweight | 01 ноя 2022 г. |
RBC Capital | Sector Perform | Sector Perform | 01 ноя 2022 г. |
Canaccord Genuity | Hold | Buy | 01 ноя 2022 г. |
Barclays | Overweight | Overweight | 02 дек 2022 г. |
RBC Capital | Outperform | Sector Perform | 09 янв 2023 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 06 янв 2023 г. |
Truist Securities | Hold | Hold | 20 дек 2022 г. |
Wells Fargo | Overweight | Overweight | 12 дек 2022 г. |
Barclays | Overweight | Overweight | 02 февр 2023 г. |
Wells Fargo | Overweight | Overweight | 01 февр 2023 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 01 февр 2023 г. |
Loop Capital | Buy | Buy | 01 февр 2023 г. |
Truist Securities | Hold | Hold | 31 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
Boehnlein Glenn S | D | 0 | 14515 | 11 янв 2023 г. |
Boehnlein Glenn S | D | 26853 | 8433 | 11 янв 2023 г. |
Boehnlein Glenn S | A | 35286 | 14515 | 11 янв 2023 г. |
Fink M Kathryn | D | 9264 | 131 | 11 янв 2023 г. |
Fink M Kathryn | D | 9395 | 116 | 11 янв 2023 г. |
Fink M Kathryn | D | 9511 | 346 | 11 янв 2023 г. |
Fink M Kathryn | D | 9857 | 1403 | 11 янв 2023 г. |
Fink M Kathryn | D | 11260 | 3417 | 11 янв 2023 г. |
Fink M Kathryn | D | 14677 | 1158 | 11 янв 2023 г. |
Fink M Kathryn | D | 0 | 5174 | 10 янв 2023 г. |
Новостная лента
Which Is the Safer Dividend Stock: Stryker or Medtronic?
The Motley Fool
12 мая 2023 г. в 09:53
Stryker and Medtronic are two of the biggest names in the medical device industry. Stryker is growing steadily, and its recent headwinds are clearing up.
16 Stocks Run Circles Around Warren Buffett Over The Long Haul
Investors Business Daily
09 мая 2023 г. в 08:00
Warren Buffett held court again at Berkshire Hathaway's shareholder meeting. But his company could learn from some other S&P 500 companies.
Got $5,000? Buy These 2 Stalwart Stocks and Hold Them Forever
The Motley Fool
03 мая 2023 г. в 10:07
Stalwarts are companies that have stood the test of time without trouble. Thermo Fisher's recent headwinds should have little impact on its long-term outlook.
BAX vs. SYK: Which Stock Should Value Investors Buy Now?
Zacks Investment Research
02 мая 2023 г. в 12:57
Investors interested in stocks from the Medical - Products sector have probably already heard of Baxter International (BAX) and Stryker (SYK). But which of these two stocks is more attractive to value investors?
Stryker (SYK) Q1 Earnings Beat Estimates, Volume Improves
Zacks Investment Research
02 мая 2023 г. в 08:25
Stryker's (SYK) first-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.